Structure-based de novo design of novel inhibitors of the MDM2-p53 interaction

被引:0
|
作者
Sun, Daqing [1 ]
Rew, Yosup [1 ]
De Turiso, Felix Gonzalez Lopez [1 ]
Bartberger, Michael D. [3 ]
Beck, Hilary P. [1 ]
Canon, Jude [4 ]
Chen, Ada [1 ]
Chow, David [1 ]
Deignan, Jeffrey [1 ]
Fox, Brian M. [1 ]
Huang, Xin [5 ]
Jiang, Min [2 ]
Jiao, Xianyun [1 ]
Jin, Lixia [2 ]
Kopecky, David J. [1 ]
Li, Yihong [1 ]
Lo, Mei-Chu [1 ]
Long, Alexander M. [5 ]
Michelsen, Klaus [3 ]
Oliner, Jonathan D. [4 ]
Osgood, Tao [4 ]
Saiki, Anne Y. [4 ]
Schneider, Steve [5 ]
Yakowec, Peter [5 ]
Yan, Xuelei [1 ]
Ye, Qiuping [2 ]
Yu, Dongyin [4 ]
Zhao, Xiaoning [1 ]
Zhou, Jing [1 ]
Olson, Steven H. [1 ]
Medina, Julio C. [1 ]
机构
[1] Amgen Inc, Therapeut Discovery, San Francisco, CA 94080 USA
[2] Amgen Inc, Pharmacokinet & Drug Metab, San Francisco, CA 94080 USA
[3] Amgen Inc, Therapeut Discovery, Thousand Oaks, CA 91320 USA
[4] Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA
[5] Amgen Inc, Therapeut Discovery, Cambridge, MA 02142 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] MEDI 147-Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction
    Watson, Anna F.
    Golding, Bernard T.
    Griffin, Roger J.
    Hutton, Claire
    Liu, Junfeng
    Lu, Xiaohong
    Lunec, John
    Newell, David R.
    Valeur, Eric
    Hardcastle, Ian R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [42] Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models
    Bowman, Anna L.
    Nikolovska-Coleska, Zaneta
    Zhong, Haizhen
    Wang, Shaomeng
    Carlson, Heather A.
    Journal of the American Chemical Society, 2007, 129 (42): : 12809 - 12814
  • [43] Potent and Orally Active Small-Molecule Inhibitors of the MDM2-p53 Interaction
    Yu, Shanghai
    Qin, Dongguang
    Shangary, Sanjeev
    Chen, Jianyong
    Wang, Guoping
    Ding, Ke
    McEachern, Donna
    Qiu, Su
    Nikolovska-Coleska, Zaneta
    Miller, Rebecca
    Kang, Sanmao
    Yang, Dajun
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (24) : 7970 - 7973
  • [44] Identification of equal affinity MDMX/MDM2-p53 interaction small molecule inhibitors
    Reed, Damon
    Mills, Nicholas
    Guy, R. Kip
    Dyer, Michael
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3404S - 3404S
  • [45] Structure-based de novo design and biochemical evaluation of novel BRAF kinase inhibitors
    Park, Hwangseo
    Jeong, Yujeong
    Hong, Sungwoo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 1027 - 1030
  • [46] Proapoptotic modification of substituted isoindolinones as MDM2-p53 inhibitors
    Grigoreva, Tatyana A.
    Novikova, Daria S.
    Petukhov, Alexey V.
    Gureev, Maxim A.
    Garabadzhiu, Alexander V.
    Melino, Gerry
    Barlev, Nickolai A.
    Tribulovich, Vyacheslav G.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (23) : 5197 - 5202
  • [47] Rational design and synthesis of 1,5-disubstituted tetrazoles as potent inhibitors of the MDM2-p53 interaction
    Surmiak, Ewa
    Neochoritis, Constantinos G.
    Musielak, Bogdan
    Twarda-Clapa, Aleksandra
    Kurpiewska, Katarzyna
    Dubin, Grzegorz
    Camacho, Carlos
    Holak, Tad A.
    Domling, Alexander
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 126 : 384 - 407
  • [48] Design and synthesis of potent, specific and orally active small-molecule inhibitors of the MDM2-p53 interaction
    Yu, Shanghai
    Qin, Dongguang
    Chen, Jianyong
    Wang, Guoping
    Ding, Ke
    Nikolovska-Coleska, Zaneta
    Kumar, Sanjeev
    Qiu, Su
    Bernard, Denzil
    Lu, Yipin
    Kang, Sanmao
    Yang, Daijun
    Wang, Shaomeng
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [49] Structure-based Design of High Affinity Peptides Inhibiting the Interaction of p53 with MDM2 and MDMX
    Phan, Jason
    Li, Zhenyu
    Kasprzak, Agnieszka
    Li, Baozong
    Sebti, Said
    Guida, Wayne
    Schoenbrunn, Ernst
    Chen, Jiandong
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (03) : 2174 - 2183
  • [50] The development of piperidinones as potent MDM2-P53 protein - protein interaction inhibitors for cancer therapy
    Liao, Guochao
    Yang, Deying
    Ma, Leilei
    Li, Wenwei
    Hu, Liqin
    Zeng, Liming
    Wu, Peng
    Duan, Lixin
    Liu, Zhongqiu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 159 : 1 - 9